China Resources Pharmaceutical (HKG:3320) unit CR Pharmaceutical Commercial completed the issue of 3 billion yuan of corporate bonds in China, a Tuesday Hong Kong bourse filing said.
The bonds carry a 1.82% coupon rate and will fall due in three years.
The firm will use proceeds from the issue to repay debt.